Peptide record

TPDB02819

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02819
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 SATPdb dbACP Antifungipept CAFPdb DRAVP 2.0 CellPPD CellPPD-MOD CPPsite3.0 PerseuCPP APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
INLKALAALAKKIL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C70H130N18O16
RDCEQGHMFPSTWYV
AL
1479.91
10.84
3
0
10
+3
-0.96
1.157
195.71
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
1
Residue Composition
number
4
A
0
R
1
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
4
L
3
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 4 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
14 reviewed residue count
C70H130N18O16 sequence-only estimate (linear, free termini)
1479.91 sequence-only estimate (linear, free termini)
10.84 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.96 sequence-only estimate (linear, free termini)
1.157 sequence-only estimate (linear, free termini)
Evidence Records 20 records
Evidence 1 Activity

Activity

MIC
Antibacterial
10-20 µM

Target

Staphylococcus aureus ATCC 29213 or MRSA

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
t 18 (4), 383-7), B. subtilis ATCC6633 (MIC ~20 uM), E. faecalis ATCC 12953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeru
Evidence 2 Activity

Activity

MIC
Antibacterial
10-30 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

2953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Sil
Evidence 3 Activity

Activity

MIC
Antibacterial
10-20 µM

Target

S. enterica

Source & Reference

dbAMP DRAMP

Other

~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Silva et al., 2020 ).
Evidence 4 Activity

Activity

MIC
Antifungal
10-20 µM

Target

Staphylococcus aureus ATCC 29213 or MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
t 18 (4), 383-7), B. subtilis ATCC6633 (MIC ~20 uM), E. faecalis ATCC 12953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeru
Evidence 5 Activity

Activity

MIC
Antifungal
10-30 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

2953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Sil
Evidence 6 Activity

Activity

MIC
Antifungal
10-20 µM

Target

S. enterica

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Silva et al., 2020 ).
Evidence 7 Activity

Activity

MIC
Antiparasitic
10-20 µM

Target

Staphylococcus aureus ATCC 29213 or MRSA

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
t 18 (4), 383-7), B. subtilis ATCC6633 (MIC ~20 uM), E. faecalis ATCC 12953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeru
Evidence 8 Activity

Activity

MIC
Antiparasitic
10-30 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

2953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Sil
Evidence 9 Activity

Activity

MIC
Antiparasitic
10-20 µM

Target

S. enterica

Source & Reference

DRAMP

Other

~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Silva et al., 2020 ).
Evidence 10 Activity

Activity

MIC
Antiviral
10-20 µM

Target

Staphylococcus aureus ATCC 29213 or MRSA

Source & Reference

DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
t 18 (4), 383-7), B. subtilis ATCC6633 (MIC ~20 uM), E. faecalis ATCC 12953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeru
Evidence 11 Activity

Activity

MIC
Antiviral
10-30 µM

Target

Escherichia coli

Source & Reference

DRAMP DRAVP 2.0

Other

2953 (MIC ~10 uM), S. aureus ATCC 29213 or MRSA (MIC 10-20 uM), S. pyogenes (MIC ~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Sil
Evidence 12 Activity

Activity

MIC
Antiviral
10-20 µM

Target

S. enterica

Source & Reference

DRAMP DRAVP 2.0

Other

~10 uM), E. coli (MIC 10-30 uM), K. pneumoniae (MIC 10-20 ~uM), P. aeruginosa 10-20 uM), S. enterica (MIC 10-20 uM) ( Silva et al., 2020 ).
Evidence 13 Activity

Activity

10% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
10% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. | Eur J Biochem | 2002
Evidence 14 Activity

Activity

50% Cell death
Toxicity
12.5 µM
Cytotoxic
50% Cell death | 12.5 | µM | target cell: Mouse fibroblasts 3T3-L1

Target

Mouse fibroblasts 3T3-L1

Source & Reference

NA
DBAASP
Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants With Extended Antibacterial Properties | J Med Chem | 2019
Evidence 15 Activity

Activity

50% Cell death
Toxicity
50 µM
Cytotoxic
50% Cell death | 50 | µM | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants With Extended Antibacterial Properties | J Med Chem | 2019
Evidence 16 Activity

Activity

45% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
45% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants With Extended Antibacterial Properties | J Med Chem | 2019
Evidence 17 Activity

Activity

<5% Hemolysis
Toxicity
8 µM
Hemolytic Cytotoxic
<5% Hemolysis | 8 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans. | Mol Divers | 2024
Evidence 18 Activity

Activity

28% Hemolysis
Toxicity
128 µM
Hemolytic Cytotoxic
28% Hemolysis | 128 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans. | Mol Divers | 2024
Evidence 19 Activity

Activity

% Hemolysis
Toxicity
40 %
Hemolytic
Hemolytic_activity: [Ref.27423268]40% hemolysis at 10µM against rat red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochim Biophys Acta. 2016 Nov 1858(11):2699-2708.
Evidence 20 Hemolysis

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.